Zhang, K., Cheng, G., Jiang, W., Kong, B., Yao, S., & Liu, X. 5-methylcytosine regulated CCNL2 promotes tumorigenesis and cisplatin resistance of ovarian cancer with therapeutic implications. BMC.
Chicago Style (17th ed.) CitationZhang, Kai, Guiyun Cheng, Wenwen Jiang, Beihua Kong, Shu Yao, and Xihan Liu. 5-methylcytosine Regulated CCNL2 Promotes Tumorigenesis and Cisplatin Resistance of Ovarian Cancer with Therapeutic Implications. BMC.
MLA (9th ed.) CitationZhang, Kai, et al. 5-methylcytosine Regulated CCNL2 Promotes Tumorigenesis and Cisplatin Resistance of Ovarian Cancer with Therapeutic Implications. BMC.
Warning: These citations may not always be 100% accurate.